Nutritional aspects of cancer-related fatigue

Journal of the American Dietetic Association
D Kalman, L J Villani

Abstract

Fatigue, which may well be the most common experience of patients with cancer, remains underappreciated by health care professionals. Perhaps one reason is that because of its complexity and many components, fatigue is not completely understood. Knowledge of fatigue models, such as the integrated Fatigue Model of Piper, can help dietitians identify potential causes of fatigue such as activity-rest patterns, and identification can lead dietitians to early intervention. Understanding cancer treatment factors, such as nausea and decreased participation in activities of daily living, that are believed to play a part in fatigue form another level on which dietitians can provide intervention. Through intervention, dietitians, working with patients and other members of the multidisciplinary team, may increase the understanding and appreciation of fatigue as well as provide relief from it. Efforts to maintain nutritional status can decrease or prevent some of the fatigue associated with cancer and its treatment. Therefore, the goal of clinical dietitians who work with a fatigued patient with cancer is to use nutrition management to minimize therapeutic side effects and maximize the patient's nutritional parameters.

References

Oct 1, 1978·Cancer Nursing·R McCorkle, K Young
Dec 1, 1979·Cancer Nursing·P J Haylock, L K Hart
Jan 1, 1992·Journal of Pain and Symptom Management·D B GreenbergD Ross
Oct 1, 1991·Cancer Nursing·M L Winningham
Feb 1, 1991·Cancer Nursing·S Pickard-Holley
Jun 14, 1990·The New England Journal of Medicine·H LudwigU Barnas
Dec 1, 1985·Cancer Nursing·J A Kobashi-SchootP F Bruning
Oct 1, 1985·American Journal of Clinical Oncology·B R CassilethB Morrin-Taylor
Jul 1, 1970·American Industrial Hygiene Association Journal·E P Grandjean
Feb 1, 1971·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C M Clark, G A Goodlad
Feb 1, 1983·The American Journal of Nursing·B E MeyerowitzF C Sparks
Sep 1, 1983·Research in Nursing & Health·G V PadillaF Heide
Jan 1, 1980·American Journal of Surgery·H C HooverJ E Fischer
May 1, 1981·The Journal of Surgical Research·J A NortonM F Brennan
Jan 1, 1981·International Rehabilitation Medicine·A Glaus
Oct 1, 1994·Research in Immunology·G Kaplan, A L Moreira
Jul 13, 1995·The New England Journal of Medicine·C Grunfeld
Apr 1, 1993·Sports Medicine·R J Shephard
Jun 1, 1993·ANS. Advances in Nursing Science·J K DixonM Hickey

❮ Previous
Next ❯

Citations

Dec 1, 2001·Journal of Pain and Symptom Management·K L KirshD Theobald
May 4, 2010·Annales pharmaceutiques françaises·P Hartvig Honoré
Nov 26, 2003·Archives of Physical Medicine and Rehabilitation·Marleen H De GrootGail A Eskes
Apr 26, 2005·International Journal of Nursing Studies·Karin AhlbergFannie Gaston-Johansson
Apr 20, 2007·Clinical Journal of Oncology Nursing·Sandra A MitchellEllen R Tanner
Jul 16, 2004·Cancer Nursing·Gülbeyaz CanAdnan Aydiner
Oct 7, 2006·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Per HartvigGunnar Wagenius
Oct 13, 2001·Cancer·H B Gutstein
Apr 6, 2001·AACN Clinical Issues·J P Finley
Aug 4, 2009·International Journal of Palliative Nursing·Susan Holmes
Apr 30, 2002·Oncology Nursing Forum·Lilian M Nail
Oct 13, 2006·The Cancer Journal·Sandra A Mitchell, Ann M Berger

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.